These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 66349)

  • 21. Standard and augmented secretin testing in chronic pancreatic alcoholic disease.
    Bordalo O; Noronha M; Lamy J; Dreiling DA
    Am J Gastroenterol; 1975 Aug; 64(2):125-32. PubMed ID: 1181915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The fluorescein dilaurate serum test following metoclopramide and secretin stimulation for evaluating pancreatic function. Contribution to the diagnosis of chronic pancreatitis].
    Malfertheiner P; Büchler M; Müller A; Ditschuneit H
    Z Gastroenterol; 1987 Apr; 25(4):225-32. PubMed ID: 3590900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secretin injection test in the diagnosis of gastrinoma.
    McGuigan JE; Wolfe MM
    Gastroenterology; 1980 Dec; 79(6):1324-31. PubMed ID: 7439637
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the influence of extrapancreatic factors (undernutrition, cirrhosis) on utilization of amino acids by the pancreas after its stimulation with secretin and cerulein].
    Jarosz M; Dzieniszewski J; Kłys W; Kunachowicz H
    Wiad Lek; 1993 Oct; 46(19-20):741-9. PubMed ID: 7975619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The secretin-pancreozymin test in the diagnosis of pancreatic insufficiency].
    Rick W
    Internist (Berl); 1970 Mar; 11(3):110-7. PubMed ID: 4928886
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of the standard and "maximal" secretin test findings in normal subjects.
    Bordalo O; Teixeira MS
    Am J Gastroenterol; 1967 Oct; 48(4):328-33. PubMed ID: 6075362
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of intravenous lipid on human pancreatic secretion.
    Edelman K; Valenzuela JE
    Gastroenterology; 1983 Nov; 85(5):1063-6. PubMed ID: 6194037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Functional changes in the pancreas in chronic pancreatitis. Secretin test].
    Tabakova TV
    Ter Arkh; 1966 Jan; 38(1):87-92. PubMed ID: 5982223
    [No Abstract]   [Full Text] [Related]  

  • 29. Pancreatic excretion test and barrier hypothesis in progression of chronic pancreatitis.
    Noda A; Hayakawa T; Horiguchi Y; Naruse S; Iinuma Y
    Am J Gastroenterol; 1978 Jun; 69(6):673-82. PubMed ID: 707463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Secretin test in the diagnosis of the Zollinger-Ellison syndrome].
    Bershadenko DD
    Klin Med (Mosk); 1983 Jan; 61(1):21-6. PubMed ID: 6339804
    [No Abstract]   [Full Text] [Related]  

  • 31. [Analysis of pancreatic function. Determination of fecal chymotrypsin and the secretin-pancreozymin test. Comparative study].
    Tympner F; Reiner T; Domschke W
    Fortschr Med; 1977 Jul; 95(27):1711-4. PubMed ID: 903053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic significance of excretory pancreatic tests.
    Bondar ZA; Tuzhilin SA
    Am J Gastroenterol; 1974 Dec; 62(6):488-96. PubMed ID: 4447097
    [No Abstract]   [Full Text] [Related]  

  • 33. [Usefulness of echography with pancreatic stimulation in the evaluation of acute pancreatitis associated with pancreas divisum].
    García Coma M; Targarona Soler EM; Marco Molina C
    Rev Esp Enferm Apar Dig; 1989 Jan; 75(1):87-90. PubMed ID: 2652214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome.
    Isenberg JI; Walsh JH; Passaro E; Moore EW; Grossman MI
    Gastroenterology; 1972 Apr; 62(4):626-31. PubMed ID: 5020875
    [No Abstract]   [Full Text] [Related]  

  • 35. [Secretin deficiency].
    Rafes IuI
    Vrach Delo; 1974; 0(7):68-71. PubMed ID: 4423764
    [No Abstract]   [Full Text] [Related]  

  • 36. The ubiquitous (and extravagant) intravenous infusion.
    Viljoen JF
    JAMA; 1977 May; 237(18):1927-8. PubMed ID: 576700
    [No Abstract]   [Full Text] [Related]  

  • 37. A Phase II Trial of Human Secretin Infusion for Refractory Type B Pain in Chronic Pancreatitis: Erratum.
    Pancreas; 2016; 45(5):e23. PubMed ID: 27077722
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics and indications for the clinical use of the intravenous secretin infusion test].
    Geller LI; Glinskaia TP; Kazimirchik AP
    Lab Delo; 1976; (11):660-2. PubMed ID: 66349
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison between bolus injection and infusion of secretin and pancreozymin in the diagnosis of chronic pancreatic disease (one hour test).
    Farini R; Del Favero G; Adorati M; Pedrazzoli S; Fabris G; Giordano P; D'Angelo A; Zotti E; Lise M; Chiaramonte M; Salvagnini M; Naccarato R
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):462-8. PubMed ID: 602625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some aspects of pancreas exocrine secretion (our experience with the maximal secretin test].
    Bordalo O
    Cah Med; 1970 Oct; 11(12):1047-53. PubMed ID: 5485216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.